Sotac Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	1,012	969.87	1,038	774.83	731.52
Other Revenue	3.47	32.7	1.35	-	-
Revenue	1,016	1,003	1,040	774.83	731.52
Revenue Growth (YoY)	1.33%	-3.57%	34.18%	5.92%	49.77%
Cost of Revenue	645.1	683.11	796.12	572.69	559.77
Gross Profit	370.77	319.45	243.53	202.14	171.75
Selling, General & Admin	36.8	35.25	40.36	42.93	30.04
Other Operating Expenses	151.65	114.6	114.96	83.31	61.93
Operating Expenses	242.5	188.21	186.33	149.01	103.24
Operating Income	128.27	131.25	57.2	53.13	68.51
Interest Expense	-41.28	-22.33	-15.51	-19.02	-5.02
Interest & Investment Income	-	5.57	1.82	0.46	0.48
Currency Exchange Gain (Loss)	-	-	-0.07	-	-
Other Non Operating Income (Expenses)	-	-3.48	-1.81	-1.11	1.33
EBT Excluding Unusual Items	86.99	111.01	41.63	33.47	65.31
Gain (Loss) on Sale of Investments	-	-	-	-	-18.36
Gain (Loss) on Sale of Assets	-	0.19	-	-	-
Other Unusual Items	-0.02	-0	-2.34	5.8	-
Pretax Income	86.96	111.2	39.64	39.27	46.95
Income Tax Expense	24.03	18.44	3.85	16.41	18.16
Earnings From Continuing Operations	62.93	92.75	35.79	22.86	28.79
Minority Interest in Earnings	-5.27	-12.49	7.02	5.93	-
Net Income	57.67	80.27	42.81	28.79	28.79
Net Income to Common	57.67	80.27	42.81	28.79	28.79
Net Income Growth	-28.16%	87.48%	48.69%	0.02%	-
Shares Outstanding (Basic)	11	11	11	8	8
Shares Outstanding (Diluted)	11	11	11	8	8
Shares Change (YoY)	-0.02%	0.67%	36.35%	-	-
EPS (Basic)	5.22	7.26	3.90	3.58	3.58
EPS (Diluted)	5.22	7.26	3.90	3.58	3.58
EPS Growth	-28.10%	86.15%	9.04%	0.02%	-
Free Cash Flow	104.77	-213.47	-338.65	-8.57	28.46
Free Cash Flow Per Share	9.48	-19.32	-30.85	-1.06	3.54
Dividend Per Share	-	0.100	-	-	2.000
Gross Margin	36.50%	31.86%	23.42%	26.09%	23.48%
Operating Margin	12.63%	13.09%	5.50%	6.86%	9.37%
Profit Margin	5.68%	8.01%	4.12%	3.72%	3.94%
Free Cash Flow Margin	10.31%	-21.29%	-32.57%	-1.11%	3.89%
EBITDA	182.32	169.54	88.16	75.89	79.77
EBITDA Margin	17.95%	16.91%	8.48%	9.79%	10.90%
D&A For EBITDA	54.06	38.3	30.95	22.76	11.26
EBIT	128.27	131.25	57.2	53.13	68.51
EBIT Margin	12.63%	13.09%	5.50%	6.86%	9.37%
Effective Tax Rate	27.63%	16.59%	9.70%	41.78%	38.68%
Revenue as Reported	1,016	1,009	1,043	778.33	733.7
Advertising Expenses	-	3.15	0.05	0.3	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.